Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00166673 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of the Navigator Continuous Glucose Monitor
A Phase 2 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00166673 is a Phase 2 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 60 participants.
The verdict
NCT00166673, a Phase 2 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study is being done to find out how accurate the Navigator continuous glucose monitor is in children. It is also being done to see if use of the Navigator can improve blood sugar control and help prevent low blood sugar events. This study has three basic parts: Use of the Navigator at home for one week without being able to see the blood sugar readings; a Baseline visit or a 24-hour admission to a research unit of the hospital to find out how well the Navigator measures the blood sugar; and then 3 months use of the Navigator at home as an aid to diabetes care.
Interventions
- DEVICE FreeStyle Navigator Continuous Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2005-08 |
| Est. Completion | 2007-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00166673
The ClinicalTrials.gov registry entry for NCT00166673 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FreeStyle Navigator Continuous Glucose Monitoring System is the first listed.
NCT00166673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00166673 about?
NCT00166673 is a clinical study titled "Pilot Study of the Navigator Continuous Glucose Monitor". This study is being done to find out how accurate the Navigator continuous glucose monitor is in children. It is also being done to see if use of the Navigator can improve blood sugar control and help prevent low blood sugar events. This study has three basic parts: Use of the Navigator at home for ...
What is the current status of trial NCT00166673?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2005-08. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00166673?
The interventions under investigation include: FreeStyle Navigator Continuous Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT00166673?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.